Ethane;N-[3-ethyl-4-[(E)-pent-2-en-3-yl]phenyl]-3-fluoro-4-(1,2,3,6-tetrahydropyridin-4-yl)benzamide
C29H41FN2O — CID 165118473
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethane;N-[3-ethyl-4-[(E)-pent-2-en-3-yl]phenyl]-3-fluoro-4-(1,2,3,6-tetrahydropyridin-4-yl)benzamide
Ethane;N-[3-ethyl-4-[(E)-pent-2-en-3-yl]phenyl]-3-fluoro-4-(1,2,3,6-tetrahydropyridin-4-yl)benzamide (PubChem CID 165118473) has the molecular formula C29H41FN2O and a molecular weight of 452.66 g/mol. Its IUPAC name is ethane;N-[3-ethyl-4-[(E)-pent-2-en-3-yl]phenyl]-3-fluoro-4-(1,2,3,6-tetrahydropyridin-4-yl)benzamide.
Molecular Properties
| Compound Name | Ethane;N-[3-ethyl-4-[(E)-pent-2-en-3-yl]phenyl]-3-fluoro-4-(1,2,3,6-tetrahydropyridin-4-yl)benzamide |
|---|---|
| PubChem CID | 165118473 |
| Molecular Formula | C29H41FN2O |
| Molecular Weight | 452.66 g/mol |
| Exact Mass | 452.32 |
| IUPAC Name | ethane;N-[3-ethyl-4-[(E)-pent-2-en-3-yl]phenyl]-3-fluoro-4-(1,2,3,6-tetrahydropyridin-4-yl)benzamide |
| SMILES | C/C=C(\CC)c1ccc(NC(=O)c2ccc(C3=CCNCC3)c(F)c2)cc1CC.CC.CC |
| InChI | InChI=1S/C25H29FN2O.2C2H6/c1-4-17(5-2)22-10-8-21(15-18(22)6-3)28-25(29)20-7-9-23(24(26)16-20)19-11-13-27-14-12-19;2*1-2/h4,7-11,15-16,27H,5-6,12-14H2,1-3H3,(H,28,29);2*1-2H3/b17-4+;; |
| InChIKey | GTEZKWPKHAAYJS-KFZHMZRQSA-N |
| XLogP | 7.88 |
| TPSA | 41.13 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 452.66 |
| LogP ≤ 5 | 7.88 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 165118473 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.